Abiomed (ABMD) Tops Q3 EPS by 3c; Narrows Margin Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
ABIOMED (ABMD) PT Lowered to $385 at Raymond James
February 1, 2019 7:38 AM ESTRaymond James analyst Jayson Bedford lowered the price target on ABIOMED (NASDAQ: ABMD) to $385.00 (from $400.00) while maintaining a Outperform rating.
... More